[Clinical care for patients with possible Brugada syndrome].
Kamakura
Shiro
S
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D015764:Bepridil / Q000627:therapeutic use; D002037:Bundle-Branch Block / Q000175:diagnosis / Q000235:genetics / Q000628:therapy; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D016757:Death, Sudden, Cardiac; D017147:Defibrillators, Implantable; D003937:Diagnosis, Differential; D004562:Electrocardiography; D006801:Humans; D009124:Muscle Proteins / Q000235:genetics; D009154:Mutation; D062554:NAV1.5 Voltage-Gated Sodium Channel; D011379:Prognosis; D015222:Sodium Channels / Q000235:genetics; D013577:Syndrome; D014693:Ventricular Fibrillation / Q000175:diagnosis / Q000235:genetics / Q000628:therapy
D000889:Anti-Arrhythmia Agents; D002121:Calcium Channel Blockers; D009124:Muscle Proteins; D062554:NAV1.5 Voltage-Gated Sodium Channel; C568320:SCN5A protein, human; D015222:Sodium Channels; D015764:Bepridil